Naomi E Clarke1, Suhail A R Doi1,2, Kinley Wangdi1, Yingxi Chen1, Archie C A Clements1,3, Susana V Nery1,4. 1. Research School of Population Health, Australian National University, Canberra, Australian Capital Territory. 2. Department of Population Medicine, College of Medicine, Qatar University, Doha. 3. Faculty of Health Sciences, Curtin University, Perth, Western Australia. 4. Kirby Institute, University of New South Wales, Sydney, Australia.
Abstract
Background: Periodic mass distribution of benzimidazole anthelminthic drugs is the key strategy to control soil-transmitted helminths (STHs) globally. However, benzimidazoles have low efficacy against Trichuris trichiura, and there are concerns about benzimidazole resistance potentially emerging in humans. Therefore, identifying alternative drug regimens is a pressing priority. We present a systematic review and network meta-analysis comparing the efficacy of 21 different anthelminthic drug regimens, including standard, novel, and combination treatments. Methods: We searched PubMed, Medline, Embase, Web of Science, and Cochrane databases and identified studies comparing anthelminthic treatments to each other or placebo. The outcomes calculated were relative risk (RR) of cure and difference in egg reduction rates (dERR). We used an automated generalized pairwise modeling framework to generate mixed treatment effects against a common comparator, the current standard treatment (single-dose albendazole). Results: Our search identified 4876 studies, of which 114 were included in the meta-analysis. Results identified several drug combinations with higher efficacy than single-dose albendazole for T. trichiura, including albendazole-ivermectin (RR of cure, 3.22 [95% confidence interval {CI}, 1.84-5.63]; dERR, 0.97 [95% CI, .21-1.74]), albendazole-oxantel pamoate (RR, 5.07 [95% CI, 1.65-15.59]; dERR, 0.51 [95% CI, .50-.52]), mebendazole-ivermectin (RR, 3.37 [95% CI, 2.20-5.16]), and tribendimidine-oxantel pamoate (RR, 4.06 [95% CI, 1.30-12.64]). Conclusions: There are several promising drug combinations that may enhance the impact of STH control programs on T. trichiura, without compromising efficacy against Ascaris lumbricoides and hookworm. We suggest further, large-scale trials of these drug combinations and consideration of their use in STH control programs where T. trichiura is present. International Prospective Register of Systematic Reviews Registration: CRD42016050739.
Background: Periodic mass distribution of benzimidazole anthelminthic drugs is the key strategy to control soil-transmitted helminths (STHs) globally. However, benzimidazoles have low efficacy against Trichuris trichiura, and there are concerns about benzimidazole resistance potentially emerging in humans. Therefore, identifying alternative drug regimens is a pressing priority. We present a systematic review and network meta-analysis comparing the efficacy of 21 different anthelminthic drug regimens, including standard, novel, and combination treatments. Methods: We searched PubMed, Medline, Embase, Web of Science, and Cochrane databases and identified studies comparing anthelminthic treatments to each other or placebo. The outcomes calculated were relative risk (RR) of cure and difference in egg reduction rates (dERR). We used an automated generalized pairwise modeling framework to generate mixed treatment effects against a common comparator, the current standard treatment (single-dose albendazole). Results: Our search identified 4876 studies, of which 114 were included in the meta-analysis. Results identified several drug combinations with higher efficacy than single-dose albendazole for T. trichiura, including albendazole-ivermectin (RR of cure, 3.22 [95% confidence interval {CI}, 1.84-5.63]; dERR, 0.97 [95% CI, .21-1.74]), albendazole-oxantel pamoate (RR, 5.07 [95% CI, 1.65-15.59]; dERR, 0.51 [95% CI, .50-.52]), mebendazole-ivermectin (RR, 3.37 [95% CI, 2.20-5.16]), and tribendimidine-oxantel pamoate (RR, 4.06 [95% CI, 1.30-12.64]). Conclusions: There are several promising drug combinations that may enhance the impact of STH control programs on T. trichiura, without compromising efficacy against Ascaris lumbricoides and hookworm. We suggest further, large-scale trials of these drug combinations and consideration of their use in STH control programs where T. trichiura is present. International Prospective Register of Systematic Reviews Registration: CRD42016050739.
Authors: Jérémy T Campillo; Naomi P Awaca-Uvon; Jean-Paul Tambwe; Godefroy Kuyangisa-Simuna; Johnny Vlaminck; Gary J Weil; Michel Boussinesq; Cédric B Chesnais; Sébastien D S Pion Journal: Parasit Vectors Date: 2021-06-08 Impact factor: 3.876
Authors: Alice V Easton; Mariam Quiñones; Ivan Vujkovic-Cvijin; Rita G Oliveira; Stella Kepha; Maurice R Odiere; Roy M Anderson; Yasmine Belkaid; Thomas B Nutman Journal: mBio Date: 2019-04-23 Impact factor: 7.867
Authors: Steffen R Hahnel; Stefan Zdraljevic; Briana C Rodriguez; Yuehui Zhao; Patrick T McGrath; Erik C Andersen Journal: PLoS Pathog Date: 2018-10-29 Impact factor: 6.823
Authors: Ariel Yang; Nahid Bakhtari; Liana Langdon-Embry; Emile Redwood; Simon Grandjean Lapierre; Patricia Rakotomanga; Armand Rafalimanantsoa; Juan De Dios Santos; Inès Vigan-Womas; Astrid M Knoblauch; Luis A Marcos Journal: PLoS Negl Trop Dis Date: 2019-08-05
Authors: Junsoo Lee; Heesoo Joo; Brian A Maskery; Jonathan D Alpern; Chanhyun Park; Michelle Weinberg; William M Stauffer Journal: JAMA Netw Open Date: 2021-06-01